Invited Speakers: Rita Valentino, PhD, Nurulain (Nur) Zaveri, PhD
Symposium: Targeting orexin systems for the treatment of sleep and substance use disorders
Speakers: Daniel Rosenbaum, PhD, Stephanie Borgland, PhD, Yanan Zhang, PhD, Andrew Huhn, PhD, MBA
Invited Speakers: Carrie Jones, PhD, Bill Stoops, PhD
Symposium: Neuroimmune systems as therapeutic targets for mental health and substance use disorders
Speakers: Amari Carter, Irma (Lisa) Cisneros, PhD, Saadet Inan, MD, PhD, Marisa Roberto, PhD
Invited Speakers: Laura M Bohn, PhD, Jean Lud Cadet, MD
Symposium: Utilizing psychedelics for the treatment of mental health and substance use disorders.
Speakers: Javier Gonzalez-Maeso, PhD, Matt Johnson, PhD, David Olson, PhD, Berra Yazar-Klosinski, PhD
Invited Speakers: Carlos Blanco, MD, PhD, Patricia Janak, PhD, Jean Bidlack, PhD
Invited Speakers: Roland R Griffiths, PhD, Bruce E Blough, PhD
Symposium: Sex differences in Addiction
Speakers: Cora Lee Wetherington, PhD, Rebecca M Craft, PhD, Suzette M Evans, PhD, Sherry A McKee, PhD
Invited Speakers: Stephen M Husbands, PhD, Alan Frazer, PhD, Sharon L Walsh, PhD
Symposium: Imaging Addiction
Speakers: Deborah C Mash, PhD, Congwu Du, PhD, David Matuskey, MD, Nelly Alia-Klein, PhD
Invited Speakers: James M Cook, PhD, Michael J Kuhar, PhD, Edward V Nunes, MD
Symposium: The conundrum of cannabis and cannabinoids
Speakers: Brian F Thomas, PhD, Jenny L Wiley, PhD, Scott E Lukas, PhD, Mark A R Kleiman, PhD
Invited Speakers: Sam Quinones, Jack Bergman, PhD, Christopher R McCurdy, PhD
Symposium: The opioid epidemic: history, formulations, regulations, and emergencies
Speakers: Lewis S Nelson, MD, Mansoor Khan, PhD, Silvia N Calderon, PhD, Andrew Coop, PhD
Invited Speakers: Thomas E Prisinzano, PhD, Robert Balster, PhD, David J Nutt, PhD
Symposium: Glial and neuroinflammatory targets for treating substance abuse disorders
Speakers: Ryan K Bachtell, PhD, Patrick M Beardsley, PhD, Keith G Heinzerling, MD, Sandra D Comer, PhD
Invited Speakers: Amy Newman, PhD, Andrew Coop, PhD, George Woody, MD
Symposium: TAAR1: from chemistry to behavior and its implications for drug abuse
Speakers: Gregory Miller, PhD, Giuseppe Cecere, PhD, David Grandy, PhD, Jun-Xu Li, MD, PhD
Invited Speakers: Kenner C Rice, PhD, James Barrett, PhD, A. Thomas McLellan, PhD
Symposium: Non-classical pharmacology of the dopamine transporter and addiction
Speakers: Maarten Reith, PhD, Bruce E Blough, PhD, Jonathan L Katz, PhD, Charles O'Brien, MD, PhD
Invited Speakers: Andrew Coop, PhD, Linda Dykstra, PhD, David Ashley, PhD
Symposium: Tobacco addiction: from basic science to policy
Speakers: Mariella De Biasi, PhD, Peter Crooks, PhD, Paul Pentel, MD, Dorothy Hatsukami, PhD
Invited Speakers: David Nichols, PhD, John Grabowski, PhD, Phil Skolnick, PhD
Symposium: Relapse to drug taking: focus on corticotropin-releasing factor
Speakers: Yavin Shaham, PhD, Eric Zorrilla, PhD, Markus Heilig, PhD, Harriet de Wit, PhD
Invited Speakers: Alexandros Makriyannis, PhD, Klaus Miczek, PhD, Mary Jeanne Kreek, MD
Symposium: New concepts in mu-opiod pharmacology
Speakers: Lakshmi Devi, PhD, John Traynor, PhD, Tom Prisinzano, PhD, Jennifer Whistler, PhD
Invited Speakers: Christian Heidbreder, PhD, R. Adron Harris, PhD, F. Ivy Carroll, PhD
Symposium: D3 receptors and addiction
Speakers: Amy Newman, PhD, Bruce Jenkins, PhD, Robert Luedtke, PhD, Michael Nader, PhD
Invited Speakers: Richard Glennon, PhD, Terry Kenakin, PhD, Thomas Kosten, PhD
Symposium: 5-HT2C receptors as novel targets for the treatment of addiction
Speakers: Kelly Berg, PhD, Kathryn Cunningham, PhD, Amarnath Natarajan, PhD, Scott Gilbertson, PhD